Related references
Note: Only part of the references are listed.2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment
Ian H. de Boer et al.
KIDNEY INTERNATIONAL (2020)
Costs and healthcare utilisation of patients with heart failure in Spain
Carlos Escobar et al.
BMC HEALTH SERVICES RESEARCH (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial
Ofri Mosenzon et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factorsN
Manuel Gorostidi et al.
NEFROLOGIA (2018)
International differences in chronic kidney disease prevalence: a key public health and epidemiologic research issue
Vianda S. Stel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
CKD Prevalence Varies across the European General Population
Katharina Bruck et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
The global burden of chronic kidney disease: estimates, variability and pitfalls
Richard J. Glassock et al.
Nature Reviews Nephrology (2016)
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
Josef Coresh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Ron T. Gansevoort et al.
LANCET (2013)
Cost of peritoneal dialysis and haemodialysis across the world
Akash Nayak Karopadi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Chapter 1: Definition and classification of CKD
Kidney International Supplements (2012)
Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis
C. L. Blacklock et al.
DIABETIC MEDICINE (2011)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
